Ibrahim T. Aldoss,

2006, M.D., Jordan University of Science and Technology, Irbid, Jordan

2007–2010, Internal Medicine at Creighton University, Omaha, NE

Ibrahim T. Aldoss, M.D., is a Hematologist-Oncologist at City of Hope® Cancer Center in Duarte, California. A renowned blood cancer expert, Dr. Aldoss specializes in diagnosing and treating disorders including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Board-certified in internal medicine, hematology and oncology, Dr. Aldoss combines a compassionate approach to care with a groundbreaking research agenda that aims to transform leukemia treatment.

Dr. Aldoss holds several leadership roles in the field of leukemia research, including serving as co-director of the Hematology Tissue Bank and the Leukemia Registry. His work focuses on optimizing outcomes for younger adults with ALL, developing more effective immunotherapies and identifying new treatment targets for harder-to-treat diagnoses. He also leads clinical trials investigating promising therapies for patients with acute leukemias.

Originally from Jordan, Dr. Aldoss earned his medical degree from the Jordan University of Science and Technology, then went on to complete his internal medicine training at Creighton University in Omaha, and a fellowship in hematology-oncology at the University of Southern California’s Keck School of Medicine in Los Angeles. He joined City of Hope in 2014, specializing in bone marrow transplants and advanced leukemia treatment and research. Dr. Aldoss has published over 100 peer-reviewed articles and regularly presents his research at conferences around the world.